Your browser doesn't support javascript.
loading
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.
Yoo, Changhoon; Lee, Sang Soo; Song, Ki Byung; Jeong, Jae Ho; Hyung, Jaewon; Park, Do Hyun; Song, Tae Jun; Seo, Dong Wan; Lee, Sung Koo; Kim, Myung-Hwan; Lee, Seung Soo; Kim, Jin Hee; Jin, Hyung-Seung; Park, Jin-Hong; Hwang, Dae Wook; Lee, Jae Hoon; Lee, Woohyung; Chang, Heung-Moon; Kim, Kyu-Pyo; Ryoo, Baek-Yeol; Kim, Song Cheol.
Afiliação
  • Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee SS; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Song KB; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Hyung J; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park DH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Song TJ; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Seo DW; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee SK; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim MH; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee SS; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim JH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Jin HS; Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Park JH; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Hwang DW; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee JH; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee W; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Chang HM; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim KP; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Ryoo BY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ryooby@amc.seoul.kr.
  • Kim SC; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. drksc@amc.seoul.kr.
Br J Cancer ; 123(3): 362-368, 2020 08.
Article em En | MEDLINE | ID: mdl-32433600
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Desoxicitidina Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Desoxicitidina Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido